clinical trial · NCT03664752
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Participants With Acne Vulgaris
Bausch Health Americas, Inc.·phase3·completed·n = 585
Acne VulgarisIDP-120 GelIDP-120 Vehicle Gel
brief summary
study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel
started
Dec 10, 2018
primary completion
May 7, 2020
completion
May 7, 2020
last updated
Oct 20, 2026
detailed description
This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel at Weeks 2, 4, 8, and 12. To be eligible for the study subjects must be at least 9 years of age and have a clinical diagnosis of moderate to severe acne
official title
A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2 Arm, Parallel Group Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol